2-46512285-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001318063.2(ATP6V1E2):c.427C>G(p.Leu143Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000292 in 1,611,530 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001318063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP6V1E2 | NM_001318063.2 | c.427C>G | p.Leu143Val | missense_variant | Exon 5 of 5 | ENST00000522587.6 | NP_001304992.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP6V1E2 | ENST00000522587.6 | c.427C>G | p.Leu143Val | missense_variant | Exon 5 of 5 | 3 | NM_001318063.2 | ENSP00000428141.1 | ||
ATP6V1E2 | ENST00000306448.4 | c.427C>G | p.Leu143Val | missense_variant | Exon 2 of 2 | 1 | ENSP00000304891.4 | |||
ATP6V1E2 | ENST00000524249.5 | n.776-21454C>G | intron_variant | Intron 4 of 4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249826Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134984
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1459238Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 725474
GnomAD4 genome AF: 0.000105 AC: 16AN: 152292Hom.: 1 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.427C>G (p.L143V) alteration is located in exon 2 (coding exon 1) of the ATP6V1E2 gene. This alteration results from a C to G substitution at nucleotide position 427, causing the leucine (L) at amino acid position 143 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at